I share some of your scepticism, a CR could well eventuate in next the Q, but there's no way to know at what stage a Permetrex's deal may be: following the release of the independent research on its performance compared to other topicals, it could be getting closer by the day.
As previously pointed out, that research was key to setting up the scene for negotiating a deal.
Phase 1b Psoriasis Results - Very Soon, page-9
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $572.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.5¢ | 31.5¢ | $1.378M | 4.308M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 927645 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |